End-to-end strategic and in-country execution for niche, high-impact medical technologies entering complex and highly regulated markets.

Acting as a trusted local partner, ALS | Costa helps medical technology companies identify opportunities, shape market entry strategy, and personally oversee implementation across Brazil and Latin America.
Discuss a Market Entry Opportunity

The Challenge

– The Challenge of Responsible Market Entry
– For innovative medical technologies, entering a new market is rarely straightforward.
– Regulatory pathways, clinical adoption, logistics, and stakeholder alignment require more than a plan
   — They demand judgment, local presence, and accountable execution.

Why ALS | Costa

  • Strategic identification of market opportunities
  • Deep experience with niche, high-responsibility and oncologic technologies
  • End-to-end ownership across regulatory strategy, clinical implementation, and operational execution
  • Hands-on execution and on-the-ground oversight
  • Trusted in-country strategic representation
  • Precision over scale, depth over volume

SELECTED EXPERIENCE

ALS | COSTA has supported the introduction and early-stage development of high-impact medical technologies across Brazil and Latin America, operating at the intersection of strategy, clinical implementation, and on-the-ground execution.

Selected engagements include:

  • Led the introduction of a complex interventional oncology therapy across multiple Latin American markets, coordinating regulatory alignment, site activation, and first-case execution.
  • Supported the market entry of first-in-class medical technologies in Brazil, shaping regulatory pathways, enabling clinical adoption, and aligning key stakeholders.
  • Designed and implemented local operational and logistics models to enable sustainable access to high-cost and highly specialized therapies.
  • Worked closely with leading centers of excellence to support early adoption, physician engagement, and procedural implementation.
  • Advised on early commercialization strategies, bridging the gap between regulatory approval and real-world clinical use.


All engagements are conducted with full confidentiality.

Who it’s for

ALS | Costa partners with medical technology companies developing first-in-class, niche, and high-responsibility therapies that require a thoughtful and execution-led entry into Brazil and Latin America.

Fewer projects
Deeper involvement
Responsible, execution-led market entry

STRATEGIC PERSPECTIVES

Strategic and in-country execution for high-impact medical technologies entering Brazil and Latin America.

2026 © Copyright by ALS | Costa – All right reserved. Developed by Studio Ochoa.
Scroll to Top